What is InBrace?
InBrace, based in Irvine, California, is revolutionizing orthodontics with its proprietary smart wire system. This advanced treatment offers a less invasive and more efficient approach to teeth straightening compared to traditional methods. The company's technology aims to provide a more comfortable and aesthetically pleasing experience for patients, positioning it as a key innovator in the rapidly evolving dental technology sector. The substantial capital injections indicate a strong belief in InBrace's ability to capture a significant share of the orthodontic market.
How much funding has InBrace raised?
InBrace has raised a total of $218.6M across 6 funding rounds:
Series A
$5.6M
Series B
$20M
Series C
$45M
Debt
$1M
Series D
$102M
Debt
$45M
Series A (2017): $5.6M, investors not publicly disclosed
Series B (2018): $20M, investors not publicly disclosed
Series C (2019): $45M supported by Novo Holdings, venBio Partners, and Vivo Capital
Debt (2020): $1M featuring PPP
Series D (2021): $102M backed by Endeavour Vision, BlackRock, RTW Investments, Marshall Wace, Soleus Capital, Farallon Capital Management, and MVM Partners
Debt (2022): $45M with participation from Horizon Technology Finance
Key Investors in InBrace
Endeavour Vision
Endeavour Vision is a leading investment advisory firm specializing in transformative healthcare technologies, particularly in medical devices and digital health. The firm empowers entrepreneurs to develop and commercialize innovative solutions that address critical unmet healthcare needs, enhancing patient care and modernizing healthcare systems.
BlackRock
BlackRock is a global investment management firm headquartered in New York City with operations across North America, Europe, Asia, and other regions. Founded in 1988, the company offers a comprehensive range of investment products and services including mutual funds, exchange-traded funds (ETFs), and alternative investments.
RTW Investments
RTW is a life sciences investment and innovation firm that focuses on biotech and medtech innovation throughout the entire lifecycle, from company creation to public companies. The firm partners with companies at various stages of development, providing not just capital but also expertise to support their success.
What's next for InBrace?
With the recent influx of major strategic investment, InBrace is poised for accelerated growth. The company is likely to focus on scaling its manufacturing capabilities, expanding its commercial reach, and further investing in research and development to enhance its smart wire technology. This funding will also support broader market penetration and potentially new product line development. The enterprise-level backing suggests a strategic focus on achieving significant market milestones and solidifying its position as a leader in advanced orthodontic treatments.
See full InBrace company page
